GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, ...

Ranavirus infections are emerging as significant threats to amphibian, reptilian, and fish populations worldwide, causing severe declines in biodiversity ...

“Vaccines will aid in the prevention of disease, but it doesn’t mean the sheep are not going to get sick,” she said. “The ...

ST. LOUIS, MO, UNITED STATES, April 15, 2025 /EINPresswire / -- Immunophotonics, Inc., a clinical-stage biotech company focused on im ...

We recently published a list of 10 Best UK Stocks to Buy According to Billionaires. In this article, we are going to take a ...

Deciphering the gut biome's, including helminths', influence on human trained immunity will unlock novel immunotherapies harnessing the immune reprogramming potential of their secreted factors and ...

Plus Therapeutics (PSTV) announces the online availability of new data on its lead compound REYOBIQ in an abstract for both an oral ...

Tolerogenic dendritic cells in the intestines are shown to reduce the immune responses caused by exposure to food proteins.

– Coherus to focus exclusively on its innovative novel oncology programs including: – LOQTORZI®, a revenue-generating and differentiated PD-1 inhibitor; – Casdozokitug, a first-in-class interleukin-27 ...

We recently published a list of 30 Best AI Stocks to Buy According to Billionaires. In this article, we are going to take a ...

Recurring infections may signal immune dysfunction. Understanding their cause can improve health and boost your defense ...

Oncolytics Biotech ®  Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has entered into a share purchase agreement (SPA) with Alumni Capital ...